MedCity News

MARCH 10, 2023

The healthcare industry of the future will be defined by interoperable systems that need to securely share critical data across devices, distributed applications, and networks. Device manufacturers play a pivotal role in the delivery of these secure and connected solutions

Medical 313

Medical Distribution Networking Manufacturing 313

European Pharmaceutical Review

JANUARY 2, 2025

As advancements in delivery systems, RNA modification technologies, and manufacturing processes address lingering challenges, the industry is gaining momentum toward broader commercialisation and clinical adoption. Maintaining agile, scalable production capacity will also be essential to stay prepared for the next global pandemic.

Manufacturing 69

Manufacturing Food and Drug Administration FDA Pharmaceutical 69

Fierce Pharma

APRIL 10, 2024

FDA chided Kilitch Healthcare India for “poor practices” tied to written procedures around microbial contamination, shoddy lab records, behaviors that could have caused contamination and quality control lapses. In a four-observation warning letter issued this week, the U.S.

FDA 218

FDA Pharmaceutical products Manufacturing Healthcare 218

Fierce Pharma

AUGUST 26, 2024

Restructuring seems to be the name of the game for many large drugmakers these days, and Belgium-based UCB is no except | Belgium’s UCB is selling off its mature neurology and allergy business—plus a manufacturing plant—in mainland China.

Manufacturing 255

Manufacturing Management Healthcare Healthcare 255

MedCity News

JUNE 22, 2022

A veteran of GE Healthcare, Joe Gasque talks about how he's growing the company's niche position in the high-paced aesthetics industry, offering services to surgeons, practitioners, medical device and injectables manufacturers.

Manufacturing 246

Manufacturing Medical Healthcare Healthcare 246

pharmaphorum

NOVEMBER 4, 2024

Accord Healthcare unveils £50m investment, backed by the UK government, that will see a new manufacturing facility built in Newcastle

Manufacturing 111

Manufacturing Government Healthcare Healthcare 111

Fierce Pharma

JUNE 20, 2024

On a revised dealmaking spree this year, Korea’s Samsung Biologics is re-tooling its long-running drug manufacturing pact with Baxter Healthcare. | The revised deal, first established back in July of 2017, will now see Baxter pay Samsung upwards of $223 million for its manufacturing services through end of 2034.

Manufacturing 204

Manufacturing Healthcare Healthcare 204

Infuse Medical

FEBRUARY 4, 2025

In todays rapidly advancing healthcare landscape, the demands placed on medical professionals are greater than ever. Traditional approachestextbooks, live demonstrations, and hands-on workshopswhile valuable, are no longer sufficient to meet the complexities of modern healthcare. billion by 2025. billion by 2025.

Training 130

Training Medical Healthcare Healthcare 130

European Pharmaceutical Review

JANUARY 18, 2023

The first good manufacturing practice (GMP) registration of a UK pharmaceutical facility for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API) has been granted since the legalisation of medical cannabis in 2018. Thus, the MHRA’s approval supports improved regulation of medical cannabis manufacturing.

Manufacturing 119

Manufacturing Medical Medicine Pharmaceutical 119

Infuse Medical

DECEMBER 17, 2024

This media becomes especially important in healthcare since it enables the clear, concise, and efficient communication of difficult medical ideas, techniques, and patient education resources. Medical video production is producing excellent videos, especially for the demands of the pharmaceutical, medical device, and healthcare sectors.

Training 130

Training Medical Healthcare Healthcare 130

European Pharmaceutical Review

DECEMBER 21, 2022

AstraZeneca has announced it is expanding its current partnership with AI-based company G42 Healthcare, by signing an agreement to manufacture innovative drugs in Abu Dhabi, aligning with Abu Dhabi’s Industrial Strategy to double the size of its manufacturing sector by 2031. Manufacturing drugs in Abu Dhabi.

Manufacturing 98

Manufacturing Pharmaceutical Healthcare Healthcare 98

European Pharmaceutical Review

OCTOBER 17, 2022

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The post Sanofi to sell Japanese manufacturing plant appeared first on European Pharmaceutical Review.

Manufacturing 104

Manufacturing Pharmaceutical manufacturing Distribution Medicine 104

European Pharmaceutical Review

JANUARY 27, 2023

The UK will be the first country to introduce a tailored framework for the regulation of innovative medicines manufactured at the point where a patient receives care, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced. Clear regulatory expectations and allowing easier product development.

Manufacturing 105

Manufacturing Medicine Consulting Engineering 105

Healthcare Success

JUNE 6, 2022

Whether you represent a hospital, health system, or multilocation practice, competing healthcare businesses are developing innovative business models—right now—and they’re targeting your market. More businesses are developing with innovative ways to disrupt the status quo and drive competition in healthcare. The answer is twofold.

Competition 109

Competition Healthcare Healthcare Marketing 109

Pharmaceutical Technology

MARCH 6, 2023

Incannex Healthcare has collaborated with New Jersey-based pharma company Catalent for the development and manufacturing of a cGMP-grade psilocybin drug product for clinical trials and potential commercial use. It will also establish cGMP manufacturing of a drug product which will be utilised in future clinical trials.

Manufacturing 105

Manufacturing Pharmaceutical Pharma Healthcare 105

Healthcare Success

FEBRUARY 24, 2025

This week's podcast dives into successful sales leadership and is relevant to most healthcare verticals, including B2B sales in SaaS, pharmaceuticals, medical device, hospitals, etc. My guest, Chris Jennings , CEO of Chris Jennings Group , reveals the essential traits of successful healthcare sales leadership. Why Listen?

Sales 65

Sales Healthcare Healthcare Prospecting 65

European Pharmaceutical Review

NOVEMBER 9, 2023

This programme was developed by the British Standards Institute (BSI) to verify companies that are taking the necessary steps in ensuring responsible antibiotic manufacturing in the global supply chain, helping to lower the spread of AMR.

Manufacturing 111

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 111

European Pharmaceutical Review

FEBRUARY 21, 2023

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API).

Medicine 132

Medicine Manufacturing Specialization Pharmaceutical 132

European Pharmaceutical Review

NOVEMBER 29, 2023

For the first time, companies across the global healthcare sector, including AstraZeneca , GSK, Novo Nordisk and Roche, have united to discuss with energy providers in China and India, about scaling renewable power across their supply chains. This step is important as these countries are key markets for pharmaceuticals manufacturing.

Manufacturing 107

Manufacturing Marketing Pharma Pharmaceutical manufacturing 107

European Pharmaceutical Review

MARCH 31, 2023

The Medicines Patent Pool (MPP) has signed sublicence agreements with three generics manufacturers to produce generic versions of cabotegravir long-acting (LA) injectable for human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). The pharma companies who will manufacture the generic versions are Viatris, Aurobindo and Cipla.

Medicine 105

Medicine Manufacturing Food and Drug Administration Food 105

European Pharmaceutical Review

JUNE 22, 2023

On 6 June 2023, the British Standards Institute (BSI) launched its Minimized Risk of Antimicrobial Resistance (AMR) certification for antibiotic manufacturing. Soulsby and Brooks explain what the new certification means for antibiotic manufacturers and the wider pharma industry, and its anticipated benefit for supply chain sustainability.

Manufacturing 97

Manufacturing Transportation Management Healthcare 97

Infuse Medical

DECEMBER 17, 2024

Mobile applications have revolutionized multiple industries, and healthcare is no exception. Medical device app development takes front stage today in changing the way healthcare is delivered. Medical device apps can be used for a wide array of healthcare functions, such as: Tracking patient metrics (e.g.,

Medical 130

Medical Healthcare Healthcare Doctors 130

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Importantly, each site features advanced technologies to support development and manufacture of these therapeutics. Materials and financing costs are high and squeezing manufacturers and their customers alike.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

European Pharmaceutical Review

JUNE 6, 2023

A new global Minimized Risk of Antimicrobial Resistance (AMR) certification has been launched to promote and demonstrate responsible antibiotic manufacturing in the global pharmaceutical supply chain. BSI, a UK standards body, developed the new certification to the Antibiotic Manufacturing Standard published in June 2022.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Pharma 98

European Pharmaceutical Review

OCTOBER 22, 2024

The UK is set to be the first country to introduce a new regulatory framework for innovative products manufactured at or close to the point of patient care, says the Medicines and Healthcare products Regulatory Agency (MHRA). Products manufactured at the point of care are eligible for the MHRA ILAP pathway.

Medicine 89

Medicine Manufacturing Safety Consulting 89

European Pharmaceutical Review

MARCH 30, 2023

A £277 million joint government and industry funding will help four UK life sciences companies to advance life sciences manufacturing projects. The funding is the first tranche of winning grants from the Life Sciences Innovative Manufacturing Fund (LSIMF). £17

Manufacturing 96

Manufacturing Government Medicine Recruitment 96

Healthcare Success

DECEMBER 6, 2022

Healthcare consumers continue to move swiftly down the paths of least resistance toward quality care. This spells trouble for healthcare organizations that cannot change with the times. 9 Healthcare Marketing Trends 2023. 9 Healthcare Marketing Trends 2023. Consumer-First Content is Essential. Google is the gatekeeper.

Healthcare 109

Healthcare Healthcare Marketing Competition 109

Pharmaceutical Technology

MARCH 31, 2023

Moderna has finalised an agreement with the government of the Republic of Kenya to establish an mRNA manufacturing facility in the country. This also demonstrates our confidence in the investment climate in Kenya and the importance of utilising mRNA technology to build resilience in healthcare security in Africa.”

Manufacturing 105

Manufacturing Government Medicine Healthcare 105

European Pharmaceutical Review

DECEMBER 23, 2022

Our ambition is to build a modern, industry-leading manufacturing network, by bringing together talented people and cutting-edge processes, technologies and data to reliably deliver high quality, affordable and sustainable medicines and vaccines to patients. Standardise manufacturing .

Manufacturing 98

Manufacturing Networking Medicine Electronics 98

Pharmaceutical Technology

JUNE 7, 2023

The manufacturing site will be completed in three phases and will produce anti-bacterial medicines and anti-malarial drugs. Fosun Pharma chairman Wu Yifang stated: “We are glad to be supported by IFC to localise pharmaceutical manufacturing and distribution in Africa.

Manufacturing 96

Manufacturing Pharma Distribution Pharmaceutical products 96

European Pharmaceutical Review

APRIL 30, 2024

What are the top three trends that you are seeing in the biopharma manufacturing space? This resulted in not only a mismatch in the required manufacturing scale but also a significant over capacity as well. Let’s talk about continuous biopharma manufacturing. I believe this is going to be an emerging trend in the market.

Manufacturing 97

Manufacturing Food and Drug Administration Biopharma Marketing 97

Pharmaceutical Technology

DECEMBER 27, 2022

The healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. Russia’s war on Ukraine dealt a blow to healthcare services in the area that had far-reaching ramifications.

Healthcare 122

Healthcare Healthcare Pharma Medical 122

Fierce Pharma

JUNE 13, 2024

On a mission to debut life science companies on the global stage, healthcare investment firm Great Point Partners is making a play for private German contract development and manufacturing organiza | On a mission to debut life science companies on the global stage, healthcare investment firm Great Point Partners is making a play for private German (..)

Manufacturing 131

Manufacturing Healthcare Healthcare 131

European Pharmaceutical Review

MARCH 21, 2024

At Clalit, which is the second largest healthcare provider in the world, I worked in several management positions and gained a broad understanding of the needs and constraints of a healthcare system. I joined Pfizer in January 2023 as a health access specialist, after working at Clalit Health Services in Israel for almost 20 years.

Healthcare 110

Healthcare Healthcare Patients Medicine 110

European Pharmaceutical Review

FEBRUARY 12, 2024

But scaling up production and ensuring global supply of sensitive biological pharmaceuticals is a remarkable process that embodies Industry 4.0 – the rapid technological advancement that is characterising the fourth industrial revolution – and the very latest in advanced manufacturing technologies.

Manufacturing 98

Manufacturing Medicine Leads Patients 98

World of DTC Marketing

MARCH 31, 2022

With the money it costs us, the Government could encourage a private company to build a manufacturing facility for insulin while offering tax incentives. Dr. Jing Luo says the list price of insulin — the price set by manufacturers but not necessarily what patients or providers pay — has increased between 300% to 500%. billion to $5.7

Insurance 240

Insurance Prescription Manufacturing Sales 240

World of DTC Marketing

OCTOBER 21, 2021

More than $170 million of this spending was for products voluntarily withdrawn by their manufacturers after clinical trials showed that they did not improve overall survival in people with various types of cancer. This is another example of just how screwed up our healthcare system really is.

FDA 234

FDA Insurance Prescription Medicine 234